Skip to results
Modify your search
NARROW
1-20 of 30
Authors: Peter Manley
Journal Article
Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial
Neuro-Oncology, noae274, https://doi.org/10.1093/neuonc/noae274
Published: 19 December 2024
Journal Article
CTNI-09. TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG): RESULTS FROM PATIENTS ON A DRUG HOLIDAY (DH) IN THE PHASE 2 FIREFLY-1 TRIAL
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii96–viii97, https://doi.org/10.1093/neuonc/noae165.0377
Published: 11 November 2024
Journal Article
NCOG-05. HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN THE PHASE 2 FIREFLY-1 (PNOC026) TRIAL OF THE TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG)
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii224–viii225, https://doi.org/10.1093/neuonc/noae165.0887
Published: 11 November 2024
Journal Article
LGG-40. TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY PEDIATRIC LOW-GRADE GLIOMA (PLGG): REVERSIBLE DECREASES IN GROWTH VELOCITY IN THE PHASE 2 FIREFLY-1 TRIAL
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.431
Published: 18 June 2024
Journal Article
Disease burden and healthcare utilization in pediatric low-grade glioma: A United States retrospective study of linked claims and electronic health records
Neuro-Oncology Practice, Volume 11, Issue 5, October 2024, Pages 583–592, https://doi.org/10.1093/nop/npae037
Published: 27 April 2024
Journal Article
CTNI-37. CLINICAL ACTIVITY OF RAF INHIBITOR TOVORAFENIB ACCORDING TO PRIOR MAPK INHIBITOR TREATMENT IN THE REGISTRATIONAL PEDIATRIC LOW-GRADE GLIOMA ARM OF THE PHASE 2 FIREFLY-1 (PNOC026) STUDY
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v82–v83, https://doi.org/10.1093/neuonc/noad179.0319
Published: 10 November 2023
Journal Article
CTNI-24. CLINICAL ACTIVITY AND SAFETY OF THE RAF INHIBITOR TOVORAFENIB IN PATIENTS WITH OPTIC PATHWAY GLIOMAS IN THE REGISTRATIONAL PEDIATRIC LOW-GRADE GLIOMA ARM OF THE PHASE 2 FIREFLY-1 (PNOC026) STUDY
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v79, https://doi.org/10.1093/neuonc/noad179.0306
Published: 10 November 2023
Journal Article
LGG-09. CLINICAL ACTIVITY OF PAN-RAF INHIBITOR TOVORAFENIB IN THE REGISTRATIONAL PEDIATRIC LOW-GRADE GLIOMA ARM OF THE PHASE 2 FIREFLY-1 (PNOC026) STUDY
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i57, https://doi.org/10.1093/neuonc/noad073.219
Published: 12 June 2023
Journal Article
Cardiac dysfunction in medulloblastoma survivors treated with photon irradiation
Neuro-Oncology Practice, Volume 9, Issue 4, August 2022, Pages 338–343, https://doi.org/10.1093/nop/npac030
Published: 23 April 2022
Journal Article
The impact of atrial fibrillation and stroke risk factors on left atrial blood flow characteristics
European Heart Journal - Cardiovascular Imaging, Volume 23, Issue 1, January 2022, Pages 115–123, https://doi.org/10.1093/ehjci/jeab213
Published: 23 October 2021
Journal Article
RARE-07. THE LANDSCAPE OF GENOMIC ALTERATIONS IN ADAMANTINOMATOUS CRANIOPHARYNGIOMAS
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii443, https://doi.org/10.1093/neuonc/noaa222.718
Published: 04 December 2020
Journal Article
QOL-41. CARDIAC DYSFUNCTION IN MEDULLOBLASTOMA SURVIVORS TREATED WITH PHOTON IRRADIATION
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Pages iii438–iii439, https://doi.org/10.1093/neuonc/noaa222.699
Published: 04 December 2020
Journal Article
Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma
Neuro-Oncology, Volume 21, Issue 4, April 2019, Pages 537–546, https://doi.org/10.1093/neuonc/noy202
Published: 18 March 2019
Journal Article
PATH-17. INCREASING VALUE OF AUTOPSIES IN PATIENTS WITH BRAIN TUMORS IN THE MOLECULAR ERA
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Pages vi161–vi162, https://doi.org/10.1093/neuonc/noy148.673
Published: 05 November 2018
Journal Article
QOL-11. SYMPTOM BURDEN EXPERIENCED BY CHILDREN WITH BRAIN TUMORS AND ITS INFLUENTIAL FACTORS
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i159, https://doi.org/10.1093/neuonc/noy059.593
Published: 22 June 2018
Journal Article
EPID-01. COMPARATIVE SURVIVAL ANALYSIS OF PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS BETWEEN BOSTON AND EGYPT
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i80, https://doi.org/10.1093/neuonc/noy059.235
Published: 22 June 2018
Journal Article
Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma
Neuro-Oncology, Volume 20, Issue 11, November 2018, Pages 1547–1555, https://doi.org/10.1093/neuonc/noy070
Published: 05 May 2018
Journal Article
PDCT-20. FEASIBILITY AND SAFETY OF SURGICAL BIOPSY FOR PATIENTS WITH DIPG: PRELIMINARY RESULTS FROM DIPG-BATS
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi188, https://doi.org/10.1093/neuonc/nox168.762
Published: 06 November 2017
Journal Article
DIPG-29. GENOMIC LANDSCAPE OF DIFFUSE INTRINSIC PONTINE GLIOMA: AN ANALYSIS OF THE DIPG-BATS COHORT
Neuro-Oncology, Volume 19, Issue suppl_4, June 2017, Page iv11, https://doi.org/10.1093/neuonc/nox083.044
Published: 31 May 2017
Journal Article
GENE-09. PRECISION MEDICINE ANALYSIS OF 203 PEDIATRIC BRAIN TUMORS REVEALS CLINICALLY RELEVANT GENOMIC ALTERATIONS
Neuro-Oncology, Volume 19, Issue suppl_4, June 2017, Page iv20, https://doi.org/10.1093/neuonc/nox083.080
Published: 31 May 2017
